Dapagliflozin ameliorates hepatic steatosis via suppressing LXRα-mediated synthesis of lipids and bile acids
Zijie Jin, Ruotong Yin, Yan Yuan, Chen Zheng, Peng Zhang, Yalin Wang, Hongbo Weng
Topics & Concepts
DapagliflozinSteatosisNonalcoholic fatty liver diseaseLiver X receptorLipogenesisUrsodeoxycholic acidEndocrinologyInternal medicinePhospholipidosisLipid metabolismChemistryEzetimibePharmacologyBiologyFatty liverBiochemistryMedicineCholesterolType 2 diabetesDiabetes mellitusNuclear receptorTranscription factorMembranePhospholipidGeneDiseaseDrug Transport and Resistance MechanismsLiver Disease Diagnosis and TreatmentCholesterol and Lipid Metabolism